Anti-angiogenic effects and regression of localized murine AML produced by anti-VEGF and anti-Flk-1 antibodies.

about

Pediatric developmental therapies: interesting new drugs now in early-stage clinical trials.Therapeutic Antibodies for Myeloid Neoplasms-Current Developments and Future Directions.

P2860

Q37301320-CDA7A5F3-EADA-4882-AE26-E3286F1BE034 Q55354182-E2AFBE7D-3B4F-4E96-A42B-0338ABCDC312

P2860

Anti-angiogenic effects and regression of localized murine AML produced by anti-VEGF and anti-Flk-1 antibodies.

Item

http://www.wikidata.org/entity/Q40411720

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Anti-angiogenic effects and re ...... EGF and anti-Flk-1 antibodies.

@en

type

Item

label

Anti-angiogenic effects and re ...... EGF and anti-Flk-1 antibodies.

@en

prefLabel

Anti-angiogenic effects and re ...... EGF and anti-Flk-1 antibodies.

@en

P1476

Anti-angiogenic effects and re ...... EGF and anti-Flk-1 antibodies.

@en

P2093

Elizabeth Tarshis

http://www.w3.org/2001/XMLSchema#string

Fanny Reichert

http://www.w3.org/2001/XMLSchema#string

Gregor Prindull

http://www.w3.org/2001/XMLSchema#string

Marc Tarshis

http://www.w3.org/2001/XMLSchema#string

Vivian Barak

http://www.w3.org/2001/XMLSchema#string

Zina Ben-Ishay

http://www.w3.org/2001/XMLSchema#string

P2860

A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

Targeting HIF-1 for cancer therapy

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

Protein tyrosine kinase inhibitors as novel therapeutic agents.

Clinical translation of angiogenesis inhibitors.

Novel agents for the therapy of acute leukemia.

Vascular endothelial growth factor: basic science and clinical progress.

Mechanisms and future directions for angiogenesis-based cancer therapies.

P304

41-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-0609.2005.00436.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15946309

http://www.w3.org/2001/XMLSchema#string

Anti-angiogenic effects and regression of localized murine AML produced by anti-VEGF and anti-Flk-1 antibodies.

about

P2860

P2860

Anti-angiogenic effects and regression of localized murine AML produced by anti-VEGF and anti-Flk-1 antibodies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698